SER earnings: a negative outcome, -5.2%

On May 15, 2019, Serina Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.2% in the window around the event. It had already run +10.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.